صيدلية اونلاين

Nexium IV 40 mg 10*5ml

$0.00 $96.70

NEXIUM IV

Alimentary System-Antacids and Defrothicants

Alimentary System-Gastro-intestinal sedatives

ACTIVE INGREDIENTS

= Additional active ingredients

Esomeprazole 40 mg.

ESOMEPRAZOLE

PRESENTATION AND DOSSAGE

VIAL: (powder for solution): 10 x 40 mg.

RELATED INFORMATION


INDICATIONS

For gastroesophagal reflux disease in patients with esophagitis and/or severe symptoms of reflux as an alternative to oral therapy when oral intake is not appropriate.Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.


CONTRA-INDICATIONS

Hypersensitivity to the esomeprazole, to other substituted benzimidazoles or to any of the excipients.


SPECIAL PRECAUTIONS

In the presence of any alarm symptom (e.g., significant unintentional weight loss, recurrent vomiting, dysphagia, hematemesis or melena) and when gastric ulcer is suspected or present, malignancy should be excluded, as treatment may alleviate symptoms and delay diagnosis. Impaired renal function: Dose adjustment is not required in patients with impaired renal function. Due to limited experience in patients with severe renal insufficiency, such patients should be treated with caution. Impaired hepatic function: Dose adjustment is not required in patients with mild to moderate liver impairment. For patients with severe liver impairment, a maximum daily dose of 20 mg should not be exceeded. Should not be used in children since no data is available. Pregnancy and lactation: Caution should be exercised when treating pregnant women. Should not be used during breast-feeding.


SIDE EFFECTS

Headache. Abdominal pain, diarrhea, flatulence, nausea/vomiting, constipation. Administration site reactions.


DRUG INTERACTIONS

Drugs metabolised by CYP2C19, such as diazepam, citalopram, imipramine, clomipramine, phenytoin etc. Warfarin or other coumarin derivatives.


DOSAGE

MANUFACTURER & DISTRIBUTER:

Manufacturer: AstraZeneca

License Holder: AstraZeneca Israel

Reviews